Research with respect to Premenstrual Dysphoric Disorder (PMDD)

(a) In general The Secretary of Health and Human Services (in this section referred to as the Secretary), acting through the Director of the National Institutes of Health, shall— (1) expand and intensify research on Premenstrual Dysphoric Disorder (referred to in this section as PMDD), including the causes, risk factors, diagnosis, and treatment of PMDD; (2) support clinical trials to develop improved treatment options for PMDD; and (3) ensure adequate representation of diverse racial, ethnic, and socioeconomic populations in PMDD-related research. (b) Surveillance and Data Collection The Secretary shall collect and publish data on— (1) the prevalence and incidence of PMDD across populations; (2) the economic and workforce impact of PMDD; and (3) barriers to diagnosis and treatment of PMDD. (c) Authorization of appropriations To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2027 through 2031.